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1 Introduction 
 
The drug development process is becoming increasingly 
more expensive over the years, which is partly caused by 
stricter testing demanded by regulatory entities for a drug to 
be accepted into the market. At the same time the reduction 
of animal experimentation has become a priority. As a result 
in silico programs in the pharmaceutical industry play an 
increasingly important role in drug discovery for the financial 
sustainability of a company. 
The ATP-binding cassette (ABC) family is composed (in 
humans) of 48 exclusive membrane exporters that are 
grouped in seven families (ABCA-G) according to gene 
similarity with respect to sequence and organization. They 
transport a wide variety of endogenous and exogenous 
compounds, which range from ions to macromolecules, via 
an  ATP-dependent  mechanism.
[1-2]  
These  transporters are 
highly expressed in a variety of tissues, among which are 
some important distribution barriers that are associated with 
drug absorption and distribution impairment. Some  
examples  are  the  intestinal  brush  border  membrane,  the 
blood-brain barrier, and the hepatocytic biliary canalicular 
membrane.
[3] 
The role of membrane transporters in 
absorption, distribution and excretion as well as the possible 
drug interaction due to binding to these transporters indicate 
the importance of membrane transporters to drug discovery 
and development, where about 1/3 of the attrition rate in 
drug  development  is  caused  by  a  poor  pharmacokinetic 
profile.
[4] 
Something as simple as a high hepatic clearance 
can render the use of a highly active, non-toxic drug 
unfeasible due to the need for very short dosage periods. 
Properties like this are often not discovered until human 
trials, which means that any drug withdrawals are extremely 
expensive for the company. In silico studies are a promising 
and inexpensive tool to avoid or at least minimize late drug 
attrition rate. Among these, quantitative structure-activity (or 
property) relationships (QSAR) have long been 
implemented in the drug discovery and development  
process. 
Given the high potential of ABC transporters for 
pharmacoketic impact and also their potential for drug-drug 
interaction, these membrane transporters are one of the 
most important targets that need to be studied during drug 
discovery. In addition, some ABC transporters including the 
Breast Cancer Resistance Protein (BCRP1, ABCG2), P- 
glycoprotein   (P-gp,   MDR1,   ABCB1),   and   the Multidrug 
Resistance-associated Proteins (MRP1-7, ABCC1-6 and 
10)
[1] 
are  strongly  associated  with  multi-drug  resistance in 
cancer cells given their ability to extrude drugs from  the 
cell.
[2] 
QSAR appears to be a particularly well suited method 
to predict ABC transport substrates since it has been shown 
that substrate recognition by the aforementioned ABC 
members relies on global physicochemical profiles rather 
than following the key-and-lock ligand binding model.
[2] 
The 
potential of QSAR to predict ABC transporter substrates 
during the R&D process has already been demonstrated by 
Desai et al.
[5] 
who reported the successful replacement of an 
in vitro automated assay with a QSAR model to predict P-gp 
substrates in an early stage of the drug  development 
pipeline of Eli Lilly. Currently, improving the accuracy of 
QSARs to predict (classify) substrates and non-substrates   
of ABC transporters remains a challenge. This is partly due 
to the multi-specific nature of the substrate recognition by 
these transporters. Different ABC family members have 
shown  redundancy  in  terms  of  substrate  recognition  and 
transport,
[2, 6] 
and in order to take advantage of this, we 
suggest a multi-label QSAR approach to address the ABC 
transport as a whole, as opposed to the traditional single- 
label QSAR approach looking at each transporter 
individually. 
Keywords: Multi-label Classification, QSAR, transporter, P-glycoprotein, Multidrug-resistance Associated Protein, Breast Cancer Resistance 
protein, BCRP1, MRP1, MRP2 
Abstract: Efflux by the ATP-binding cassette (ABC) transporters 
affects the pharmacokinetic profile of drugs and it has been 
implicated in drug-drug interactions as well as its major role in 
multi-drug resistance in cancer. It is therefore important for the 
pharmaceutical industry to be able to understand what 
phenomena rule ABC substrate recognition. Considering a high 
degree of substrate overlap between various members of ABC 
transporter family, it is advantageous to employ a multi-label 
classification approach where predictions made for one 
transporter can be used for modeling of the other ABC 
transporters. Here, we present decision tree-based QSAR 
classification models able to simultaneously predict  substrates 
and non-substrates for BCRP1, P-gp/MDR1 and MRP1 and 
MRP2, using a dataset of 1493 compounds. 
To this end, two multi-label classification QSAR modelling 
approaches were adopted: Binary Relevance (BR) and 
Classifier Chain (CC). Even though both multi-label models 
yielded similar predictive performances in terms of overall 
accuracies  (close  to  70%),  the  CC  model  overcame  the 
problem of skewed 
substrates compared 
common   problem   in 
performance towards identifying 
with non-substrates, which is a 
the   literature.   The   models   were 
thoroughly validated by using external testing, applicability 
domain and activity cliffs characterization. In conclusion, a 
multi-label classification approach is an appropriate 
alternative for the prediction of ABC efflux. 
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In traditional supervised learning, among n training 
instances (compounds in the dataset), each instance 
(compound) is assumed to be associated with a single 
response (called label). In other words, in a single-label 
classifier, each compound is classed under one label 
(response),  e.g.  active  or  inactive.  So  for  each response 
(label), a different classifier is produced which is independent 
from the classifier produced for other labels.
[7] 
However,  
there  are  cases  where  instances,  due  to  their 
complexity, might have various simultaneous responses, 
which is the same as saying that an instance is associated    
to a set of various labels rather than just one. This is the   
case of the ABC transport problem, where different 
compounds are effluxed by different types of ABC 
transporters, and it constitutes a multi-label classification 
problem. So, in this scenario, the machine learning 
algorithm produces a multi-label classifier, which can be 
viewed as a set of single-label classification models, one per 
label (response).
[7-8]
 
However, one of the big issues in multi-label machine 
learning is that labels can have interdependency between 
them
[8]
. Correlation between labels potentially holds 
important  information  about  the  modelled  problem,  and 
accounting for this is crucial in facilitating the learning 
algorithm
[9]
. As a result, the main goal in multi-label machine 
learning  is  to  enable  the  detection  of  these relationships. 
This means that the considerable overlap between 
substrates (and inhibitors) of various ABC transporters 
should be exploited from the data mining standpoint to 
improve the model performance. 
Within multi-label classification techniques, one of the 
most widely used problem transformation methods is Binary 
Relevance (BR), which decomposes the multi-label problem 
into a binary problem for each label separately. A regular 
single-label classifier is then applied to predict the 0/1 class 
in every separate label ignoring the information from the 
remaining labels. The separate predictions from all the 
single-label classification tasks are finally gathered in one 
multi-label prediction.
[8, 10] 
Consequently, BR has a major 
drawback by assuming label independence. By separating 
the labels one is in fact losing potentially useful information 
and   it   leads   to   a   situation   like   predicting   impossible 
coexisting labels in practice.
[8, 10] 
An alternative to this is the 
classifier chain (CC) method that is able to address label 
dependency.
[10] 
In this technique, the different labels 
originating    from    single-label   models   communicate  the 
learned information to each other, in a sequential fashion. 
A multi-label approach has recently been applied to 
classify inhibitors/non-inhibitors of two transporters,  P-gp 
and BCRP1 
[11]
, although the authors reported no value in 
accounting for label overlap for the inhibitors of these two 
proteins. Here, we have focused instead on the 
substrates/non substrates of four major ABC transporters, 
namely BCRP1, MDR1/P-gp, MRP1, MRP2, using novel 
multi-label classification methods. The goal was to assess 
the potential value of taking into account the data overlap 
amongst transporters in terms of the predictive accuracy of 
the classifier, as well as finding  molecular  characteristics 
that are unique to, or those that overlap between the 
substrates of various transporters. The two previously 
mentioned multi-label modelling schemes, BR and CC, were 
employed where the only difference between them is the 
absence or presence of communication between transporter 
models, respectively. A comprehensive validation routine 
including the characterization of the applicability  domain 
(AD) and activity cliffs (AC) were carried out for the models. 
The predictive performance was analyzed against each 
model’s applicability domain and activity cliff analysis, in the 
attempt of providing a more holistic, in-depth interpretation 
of the models’ true worth. To our knowledge this is the first 
reported multi-label classification model for the prediction of 
ABC substrates (S) and non-substrates (NS), providing 
insight on transporter relationship with regard to binding 
patterns. 
 
2 Experimental Section 
 
2.1 Dataset 
 
A dataset of 1493 compounds was compiled from the 
substrate data available on the Metrabase database
[12]
 
(accessed on October 2014) for six ABC transporters: 
BCRP1,   MDR1,   MRP1,   MRP2,   MRP3   and   MRP4. All 
instances were divided into two classes: substrates and non-
substrates. The collection of SMILES provided was checked 
for repetitions and isomers using ACD Labs, and mixtures 
were removed. Repetitions were merged and, for cases of 
conflicting information, the principle of minimum evidence 
was applied, by which all compounds with at least one case 
of reported substrate property were regarded as potential 
substrates and so, they were classified as substrates. This is 
a valid approach considering that all the 
initial data collected from Metrabase was selected based on 
quality standards.
[12]
 
Prior to any modelling or modelling-related task the dataset 
was submitted to a stratification procedure as described by 
Sechidis et al.
[13]
. The authors show that this  procedure 
leads to data subsets with more balanced class label 
distributions in a series of benchmark datasets. That is, this 
procedure    maximizes    transporters    distribution    across 
different data partitions. This procedure was implemented in 
R using the provided pseudo-code. Consequently, the 
dataset was divided into training (TR), internal validation (IV) 
and test (TE) set in a proportion of 6:2:2 (895 + 299 + 299 
compounds), respectively, with similar distribution of 
substrates and non-substrates in TR, IV and TE. For larger 
datasets, i.e. BCRP1, MDR1, MRP1 and MRP2 compounds, 
there was only a negligible imbalance of data with the 
substrate (S) to non-substrate (NS) ratio of 1.7, 1.3, 1.0 and 
1.2, respectively (see Figure 1). However, for the transporter 
classes associated with smaller datasets, namely  MRP3  
and MRP4, the S to NS ratio was around 2.5, which led to 
insufficient number of non-substrates for modelling and 
validation. Therefore, these two transporters were 
eliminated and the remaining four transporters were 
investigated. 
 
2.2 Calculation of Molecular Descriptors. 
 
Molecular descriptors were calculated using ACD/labs logD 
suite v12.5 and MOE 2013, using the SMILES codes 
retrieved from Metrabase. Using ACD, prior to molecular 
descriptors calculation, all structures were submitted to 
desalting. In MOE, the compounds’ structures were washed 
(counter ions were removed) and minimized. Molecular 
mechanics minimization was initially performed using 
MMFF94x, followed by a second minimization using 
quantum mechanics Self-Consistent Field (SCF), where 
partial charges were assigned using the PM6 Hamiltonian. 
The PM6 semi-empirical method was added to MOE as a 
MOPAC  2009
[14] 
extension.  After  descriptor  calculation, all 
external, non-variant and mainly zero-valued descriptors 
(with ≥97% zero values) were removed. No single charge- 
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assignment method was selected over any other, across 
homologous descriptors, as it has been shown that different 
charge assignment methods have led to variable success in 
modelling  different  datasets  in  the  past.
[15]   
This  allows a 
data-driven selection of charge-related molecular 
descriptors using PEOE vs PM6 methods, as well  as 
various descriptors derived from semiempirical methods, 
AM1, PM3 and MNDO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic summary of transporter overlap represented in the Venn diagram. Below each transporter label are the total number of 
instances (in a square) in the full dataset, and the corresponding amount of substrates and non-substrates. 
 
 
2.3 Pre-processing feature selection. 
 
A total of five feature sets derived from five different feature 
selection techniques were produced for each of  the  four 
ABC transporters. Five different feature selection methods 
were implemented using the popular data mining tool Weka 
3.6: three filter methods, namely Genetic Algorithm (GA), 
Greedy Stepwise search (GS) and ReliefF (RfF); and two 
wrapper methods, namely C4.5 Decision Tree-Genetic 
Algorithm (J48-GA) and Random Forest-Greedy Stepwise 
search (RF-GS). For detailed information on the functioning 
of   filter   and   wrapper   methods   please   refer   to   the 
literature.
[16-17] 
All feature selection methods were run using 
the TR set only. Filter methods were implemented with 
CfsSubsetEval attribute evaluator (which selects the subsets 
of features that are highly correlated with the class while 
having low intercorrelation), and wrapper methods were 
implemented with ClassifierSubsetEval (classifier subset 
evaluator in Weka). For the GA method the following 
0.8 and 0.01 crossover and mutation probabilities, and both 
the population and generation 
0.8 and 0.01 crossover and mutation probabilities, and both 
the population and generations size were set to  100,  to 
allow sufficient exploration of the feature space. GS and RfF 
were implemented using default settings (with the latter 
coinciding with previously reported settings)
[18]
. 
Within the wrapper methods RF-GS and J48-GA were 
implemented by combining two search algorithms (GS and 
GA), respectively, with two classifiers (RF and J48). In J48- 
GA, the settings for the GA feature searcher were the same 
as the ones used for the GA filter method. As for the J48 
classifier within the wrapper, the pruning method was 
optimized by 10-fold cross validation. When applicable, the 
confidence factor was optimized in a range between 0.1 and 
 
0.5 (with a 0.1 step). All other conditions in J48 were set to 
default values. In the RF-GS method the trees were limited 
to a maximum depth of 3, as the focus is tree number not 
tree depth. The number of trees (ranging from 1 to 25) was 
optimized using the 10-fold cross-validation root-mean 
squared error. 
To minimize local-minima effects that have been particularly 
reported for GA
[19]
, for all feature selection methods 10-fold 
cross   validation   was   repeated   5   times   using  different 
random seeds, and ranking scores were averaged across 
the 5 runs. The top 20 features were selected from the 
average ranking. 
 
2.4 Multi-label QSAR models. 
 
Each of the five feature sets obtained from the feature 
selection routines were subsequently used to train a J48 
model (Weka 3.6), for each of the labels (transporters). J48 
training used the same parameters as described for the J48- 
GA feature selection method mentioned above. These 
models were then tested on an independent internal 
validation (IV) data subset. This corresponds to a total of 20 
experiments testing five different feature sets for each of the 
four ABC transporters. The best feature set for each 
transporter was selected according to the highest Matthews 
correlation coefficient (MCC) and geometric mean between 
sensitivity and specificity (G-mean) in the IV set. 
The best J48 models (using the best feature selection 
conditions) were selected for each of the training sets 
(BCRP1=288, MDR1=580, MRP1=111, MRP2=145). 
The multi-label BR model was obtained by gathering the 
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1 
𝐿 
multi-label CC model each label (transporter) in the 4-label 
chain uses the best descriptor set previously optimized for 
the BR model. In addition, as it can be seen in Figure 2, 
each label in the CC model uses prediction sets from 
previously available labels. In summary, in the CC model 
every label (transporter) in the chain is trained using the 
prediction sets from all previous labels, along with a set of 
molecular descriptors (previously selected).  To illustrate 
this, label #3 for example, will be trained with a set of 
molecular descriptors as well as class predictions for label 
 
predictions from these four best single-label models into one 
global prediction output. In this case, whenever a new query 
compound needs to be predicted it would be  passed 
through all four ABC models and a set of label predictions 
would be produced. For the multi-label CC model, the 
schematic representation of CC is depicted in Figure 2. The 
transporters were ordered according to descending order of 
dataset size, based on the theoretical expectation that larger 
datasets will have a better chance of providing useful 
information to smaller datasets than the other way around. 
Accordingly, the order of the labels in the classifier chain 
was P-gp/MDR1 > BCRP1 > MRP2 > MRP1. To build the 
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#1 and #2 
Several multi-label predictive accuracy measures 
were used, namely the harmonic mean  between 
precision and  recall (F1), Precision (P)  and  Recall   (R), 
calculated  according  to  Tsoumakas  and  Katakis 
[21-22]
. 
Hamming Loss (HL) was used solely to monitor the  
impact of each label on the multi-label model’s 
performance, during model building. 
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Figure 2. Schematic representation of multi-label  classifier chain 
training. 
 
 
Overall each transporter was submitted to an independent 
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and parallel process of feature selection, model optimization 
and training, and finally testing. All these steps were 
performed in parallel on the same datasets for CC and BR   
in order to: 1) allow comparability between both types of 
model at every level, and 2) assess the value of addressing 
the overlap in the data, by fixing all other conditions in both 
modelling workflows. Throughout the paper the following 
notation <single-label model> - <multi-label model> will be 
used whenever a specific single-label model within the CC 
or the BR models is mentioned. 
 
2.5 Model validation The single-label performance 
measures used for single-label model assessment are 
defined below 
[20]
, where TP, TN, FP and FN stand for  
the   numbers  of   true   positives,  true   negatives, false 
positives and false negatives, respectively. These 
correspond to Sensitivity (SEN), specificity (SPE), Matthew’s    
correlation    coefficient    (MCC),    and   the 
In these measures, Yi and Zi correspond to the set of 
observed and predicted labels, respectively, for the i-th 
compound, N corresponds to the number of compounds in 
the dataset, and L corresponds to the number of modelled 
labels. The Δ symbol denotes the symmetric difference 
between two sets of label values (observed and predicted,   
in this case), which is equivalent to the XOR boolean 
operation. 
As substrates are more frequent than non-substrates in 
all labels, a balanced accuracy (bACC) was used to take 
into account this when assessing predictive performance, 
which consisted of the average G-mean across every label j 
(which, in turn, can be considered as the single-label 
balanced accuracy). To evaluate the balance between 
substrate and non-substrate performances across  
instances, ΔPR measures the average deviation in precision 
and recall between substrates and non-substrates. 
 
G    
geometric mean between SEN and SPE  (G-mean). 𝑏𝐴𝐶𝐶 = 𝑆𝐸𝑁 ×𝑆𝑃𝐸 
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∆𝑃𝑅 = 
2
 
threshold has been reported as a sensible value above 
which compounds are visibly  similar.
[28-30]
 
 
 
 
2.6 Applicability Domain 
 
For any QSAR model, it is necessary to define the domain   
of applicability to ensure its reliability in the prediction of 
properties of external compounds. In this study, the 
applicability domain (AD) of all the single label models used 
in the generation of multi-label BR and CC models were 
characterized. To determine the AD, the distance to the 
model based on the standard deviation (STD) of the 
predicted values (or labels) from the ensemble of various 
models was used, as this has been shown to be the most 
successful method in quantifying predictive reliability across 
chemical space in the data.
[23-27] 
This technique capitalizes 
on the concept that the disparity between predictions 
computed from a group of models (ensemble) is a direct 
consequence of prediction reliability. A small standard 
deviation will equate to highly reliable predictions, whereas   
a larger value signals unreliable predictions. It has been 
demonstrated that the disagreement between models leads 
to a better separation between reliable and unreliable 
predictions     compared     to     traditional    structure-based 
measures.
[27]
 
In this work, J48 models were developed for 10 random 
samples of training set data, each sample comprising 80% 
of the training set compounds. 
2.8  Visualization of chemical space 
 
 
 
3 Results 
 
3.1 Multi-label QSAR models 
 
In   this   work,  the   main   goal  was   to   model  four   ABC 
𝑦 − 𝑦  L transporters  in  such  a  way  that  allows  accounting  for 
𝑆𝑇𝐷 = 
  K  
𝑁 − 1 
possible underlying correlations between labels ( i.e. 
transporters). Multi-label classification is the appropriate 
approach to achieve this. By comparing a  multi-label 
method that takes into account label interaction (i.e., CC) 
STD values were calculated for each compound  using 
the equation above. Here, 𝑦K is the class label prediction 
using model m and 𝑦  is the average of all prediction  outputs 
for this compound by N models. For classification models 
(which is the case here) predictions y take the form of 
probabilities. By setting increasingly larger STD thresholds 
(with increments of 0.05), which can also be perceived as 
increasing distance to the model’s reliability core, more 
compounds become included in the model. By performing 
this kind of scanning through the model’s space, one is able 
to establish a profile of reliability as a function of STD. In this 
case we used % correct predictions, the so-called accuracy 
as our measure of reliability. 
 
 
2.7 Activity cliffs 
 
To search for possible activity cliffs, the similarities between 
all pairs of compounds were calculated using the well-known 
Tanimoto coefficient (Tc)  applied  on 1024 bit Morgan 
circular fingerprints (equivalent to the extended connectivity 
fingerprints [ECFP], calculated using  the  RDkit  module  in  
python),  for  a  radius  of 2.Following the criteria for activity 
cliffs used by several authors
[28-30]
, we defined as an activity  
cliff  any substance  that  has  a  different  class  than  the 
majority 
class of the 3 nearest training neighbors, which must all 
show  a   Tc  >   0.55  to   the  analyzed  compound.   This 
with an alternative method that assumes labels to be 
independent (i.e. BR) one is able determine whether label 
interaction, in fact, exists. Both multi-label classifiers were 
trained using the best features selected by various feature 
selection methods for each transporter, and they differ only 
in the use of previous label predictions as  additional 
features (in the case of CC). The rational for the use of multi-
label methods was the overlap observed in the dataset as 
can be seen from the results of the Chi-squared test 
measuring the correlations between labels (Table 1). These 
multi-label methods were compared in terms of their 
predictive ability in the classification of various ABC 
transporters’ substrates and non-substrates. 
 
 
Table 1. Values of the Chi-squared test measuring correlation 
between labels. The smaller the Chi-squared  value,  the stronger 
the change of true  correlation. 
MDR1 MRP1 MRP2 
 
BCRP1 0.001 0.001 <0.001 
MDR1 <0.001 0.679 
MRP1 <0.001 
 
 
Within each multi-label model it  is  necessary  to 
make sure that each one of its single-label models 
provides  a   reasonable  input  to   the   global multi-label 
In order to gauge how wide is the chemical space of the built 
models, with relation to  the  real-world  drug chemical 
space, the ABC transporter data was overlaid against the 
DrugBank chemical space. In order to visualize   the   
chemical   space   coverage, t-Distributed 
Stochastic  Neighbor  Embedding  (t-SNE)
[31] 
was chosen 
as the multidimensional scaling technique. This  
technique is one of the  most  successful in  conserving 
the  multidimensional  structure  of  the  data  during  its 
projection   into   a   low-dimensional   plot.
[31]  
t-SNE was 
employed over a set of 1024 bit Morgan circular fingerprints 
(RDKit equivalent of ECFP), calculated for a radius of 2. To 
compute the t-SNE projection, an implementation  in   
python,  provided  by   the developer 
(https://lvdmaaten.github.io/tsne/#implementations),  
was used. 
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model. Firstly, we selected the best single-label  J48 
model for each transporter out of a pool of five models 
obtained from various pre-processing feature selection 
methods. The results showed that the GS method led to 
the best model for BCPR1, while J48-GA led to the best 
models for MDR1 and MRP1; and  ReliefF  led  to  the 
best model for MRP2 (Supporting Information SI  1). 
Table 2 shows the performance of the best single-label 
models. 
Secondly, to validate the inclusion of each label, the 
impact of removing a label or the addition of new labels 
on   the   overall  performance  of  BR   and  CC   models, 
respectively, was assessed by HL, with respect to the IV 
set (Figure 3). Both BR and CC models show a constant 
impact in HL by the presence of all labels, which is 
depicted by a constant HL value as the chain grows, in 
CC, and when different labels are  removed in  turn, in BR 
(Figure 3). This observation justifies the presence of each 
label in the multi-label models. The same is observed in 
the TE set where no particular label stood  out in terms of 
impact on HL performance (Figure  4) which means no 
label is causing degradation of the predictive
 performance. 
 
 
Table 2. Test set (TE) performance of the  single-label models for  individual transporters using the  best  set  of  features with  (CC) 
or without (BR) the use of the predicted ABC binding class of the preceding transporters in the classifier chain. 
 
 MDR1  BCRP1  MRP2  MRP1 
 (n=195)  (n=87)  (n=41)  (n=36) 
 
J48-GA GS  
GS 
pMDR1 
 
RfF 
RfF 
pMDR1 
pBCRP1 
 
J48-GA 
J48-GA 
pMDR1 
pBCRP1 
pMRP2 
    
 
CC model (IV) 
0.35 
 
0.35 
BR model (IV) 
 
0.33 
 
0.31 
 
0.29 
 
0.27 
 
0.25 
 
 
 
 
 
 
 
 
 
 
 
MDR1 
BCRP 
 
 
 
 
 
 
 
 
 
 
 
MDR1 
BCRP 
MRP2 
 
 
 
 
 
 
 
 
 
 
 
MDR1 
BCRP 
MRP2 
MRP1 
0.30 
 
0.25 
 
0.20 
 
0.15 
 
0.10 
 
0.05 
 
0.00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MDR1 BCRP1 MRP2 MRP1 
chain growth Removed label 
 
Figure 3. Impact of each label on the overall performance of the CC and BR models, tested on the IV set. The graph for CC   depicts 
the evolution of the model’s performance as labels are being added to the chain, whereas the graph for BR depicts the model’s 
performance when each of the labels is removed, in turn. 
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Figure 4. Impact of each label on the overall predictive TE performance of the CC and BR models. The graph for CC depicts the evolution 
of the model’s performance as labels are being added to the chain, whereas the graph for BR depicts the model’s performance when 
each of the labels is removed, in turn. 
 
 
At the multi-label level, Table 3 indicates a good 
performance with an overall  F1  of  approximately  70% 
for both BR and CC models. The results also show that 
both models performed very similarly, however attention 
must be drawn to the fact that the modelled data is 
imbalanced both at the label  level  (i.e.  some 
transporters have more data than others) and at  the  class 
level (i.e. within each transporter there is more substrates 
than non-substrates). This means that commonly 
employed measures, such as F1,  precision and recall, 
will be leveraged by the  majority  label and  the majority 
class, and therefore they are not ideal to assess these 
imbalanced problems. Alternatively, bACC has been 
designed to overcome this issue. Table 3  shows that 
bACC has a higher  score  for  CC.  Additionally the CC 
model shows less discrepancy between the ability to 
predict substrates and non- substrates, shown by the 
absolute difference between both with regard to precision 
and recall (ΔPR). This  means the CC model achieves the  
best  balance  in terms of classifying both substrates and 
non-substrates. Moreover, a comparison of single-label 
(individual transporter) models used to develop BR and 
CC (Table 
2) shows that the two single-label models that include a 
predicted label as a feature (BCRP1, and MRP1) have 
improved SEN-to-SPE balance, which supports the 
existence of label correlations and the advantage of  taking 
them into account when modelling ABC transport data by 
using CC instead of  BR. 
Table 3. Summary of performance measures of  the  final BR  
and CC models in the test set. Underlined font  marks  the values 
that are better than their direct counterpart models. 
 
 
 
3.2 Molecular descriptors in single-label elements of BR 
and CC 
 
As it was explained in previous sections, the molecular 
descriptors used in J48 models have been selected by the 
best pre-processing feature selection methods for each 
transporter dataset followed by the embedded J48 feature 
selection. Roughly the same number of molecular 
descriptors was provided to the J48 algorithm for the 
modelling of each transporter, however the number of 
descriptors used to build each tree decreased along  the 
order of the labels in the chain, i.e. MDR1, BCRP1, MRP2, 
and MRP1. Moreover, recall that the same set of molecular 
descriptors was provided to J48 for the single-label 
constituents of the BR and CC models, but single-label 
elements of CC employ additional predictors, i.e. the 
predicted substrate class of the previous transporter(s) in 
the chain. 
Molecular descriptors used in single-label J48 models 
have been presented in the Supporting information SI 2 in 
the form of a series of IF-THEN rules. These have been 
automatically compiled from the tree in Weka’s output using 
a python script and can be easily implemented for further 
use. Given the large number of molecular descriptors 
incorporated in some J48 models, these descriptors can be 
ranked according to the statistical importance and the most 
important molecular descriptors may be identified. Tables 4 
and 5 show the importance of molecular descriptors in J48 
models for different transporters in BR and CC models, 
respectively. These molecular descriptors have been 
described in Supporting Information SI 3. In order to 
calculate the feature importance, the molecular descriptors 
used in the models were ranked according to the number of 
compounds that were directly affected by each descriptor at 
any point of the tree. In this way, descriptors selected earlier 
on for major branches of trees are more important  than 
those selected later on to classify a smaller number of 
compounds. Table 5 shows that the molecular descriptors 
selected by J48 algorithm for BCRP1 and MRP1 include a 
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Performance measures BR CC 
F1 69.6 % 69.2 % 
bACC 68.7 % 69.0 % 
Precision 70.4 % 70.0 % 
Recall 70.0 % 69.6 % 
ΔPR 20.6 % 17.4 % 
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transporter substrate class predicted by the previous 
transporters in the chain, and both predicted labels used in 
both models affected more than 50% of the training data 
(see Table 5). 
Due to the design of the CC model that placed MDR1 
model as the first label, the single-label MDR1 model used 
in both multi-label BR and CC models is the same, i.e. no 
predicted ABC label was used as a feature in the modelling 
of this transporter. As a result MDR1 descriptors reported in 
Tables 4 and 5 are the same. For BCRP1, a comparison of 
Tables 4 and 5 shows that some of the molecular 
descriptors in the BR model have been replaced by the 
predicted MDR1 class as an important feature in the CC 
model of BCRP1. On the other hand, the single label MRP2 
model developed by J48 did not pick predicted MDR1 or 
predicted BCRP1 labels, and only molecular descriptors 
were selected as the model features. As a result, the top 
descriptors used in the single label MRP2  models  within 
both BR and CC models are the same (see Table 4 and 5). 
For MRP1 models, a comparison of Tables 4 and 5 shows 
that the models developed for CC and BR are different, as 
the predicted MRP2 labels have been used in the multi-label 
MRP1 model built by the CC model. The MRP1 model for 
CC used the predicted MRP2 label as the second most 
important feature replacing the polar volume. 
 
 
 
Table 4. Descriptor importance calculated from the  relative amount (%N) of  compounds classified using every given feature within the BR 
model. See Supporting Information SI 4  for descriptor  definitions. 
MDR1 %N BCRP1 
(GS) 
%N MRP2 
(RfF) 
%N MRP1 
(J48-GA) 
%N 
(J48-GA)    
VDistMa 100 Num_Rings_4 100 ast_violation_ext 100 Q_VSA_POL 100 
FCharge 85 Q_VSA_FPPOS 94 PEOE_VSA_FPNEG 65 vsurf_Wp1 70 
a_nH 80 SlogP_VSA7 82 vsurf_CW2 61 Q_VSA_FPPOS 53 
b_max1len 64 b_ar 68 reactive 54 FCASA+ 38 
PM3_LUMO 63 opr_nring 53 Fi(B) 34 chi1v_C 34 
PEOE_VSA+6 52 a_nF 30 b_rotR 24 b_rotR 30 
SMR_VSA2 45 glob 24 opr_leadlike 16 b_max1len 15 
a_acc 27 a_ICM 23 Q_VSA_FHYD 12 Kier3 14 
b_ar 25 PEOE_VSA-3 22 vsurf_HB2 11 
  
dens 22 LogD(6.5) 19 Fi(A) 4 
  
PEOE_VSA-6 20 MNDO_LUMO 18 
    
Num_Rings_5 16 SMR_VSA4 9 
    
FCASA- 13 LogD(5.5) 5 
    
vsurf_Wp5 11 PEOE_VSA-4 3 
    
vsurf_Wp6 10 PEOE_VSA-1 2 
    
SlogP 8 vsurf_R 2 
    
Rule_Of_5 8 LogD(7.4) 2 
    
PM3_E 8 
      
MW 3 
      
vsurf_CW8 2 
      
PEOE_VSA_NE 2 
G 
Polarizability 2 
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Table 5. Descriptor importance calculated from the amount of compounds classified using every given feature within the CC model. 
 
MDR1 %N BCRP1 %N MRP2 %N MRP1 %N 
(J48-GA)  (GS)  (RfF)  (J48-GA)  
 
VDistMa 100 Num_Rings_4 100 ast_violation_ext 100 Q_VSA_POL 100 
FCharge 85 Q_VSA_FPPOS 94 PEOE_VSA_FPNEG 65 pMRP2_RfF 70 
a_nH 80 SlogP_VSA7 82 vsurf_CW2 61 vsurf_D7 46 
b_max1len 64 b_ar 62 reactive 54 b_rotR 30 
PM3_LUMO 63 pMDR1_J48-GA 55 Fi(B) 34 Q_VSA_FPPOS 24 
PEOE_VSA+6 52 opr_nring 48 b_rotR 24 rings 17 
SMR_VSA2 45 glob 46 Q_VSA_FHYD 12 b_max1len 14 
a_acc 27 a_nF 30 vsurf_HB2 11 
  
b_ar 25 PEOE_VSA-3 22 
    
dens 22 MNDO_LUMO 21 
    
PEOE_VSA-6 20 vsurf_CW2 19 
    
Num_Rings_5 16 LogD(6.5) 19 
    
FCASA- 13 a_ICM 9 
    
vsurf_Wp5 11 LogD(5.5) 7 
    
vsurf_Wp6 10 SMR_VSA4 7 
    
SlogP 8 a_aro 4 
    
Rule_Of_5 8 PEOE_VSA-4 3 
    
PM3_E 8 vsurf_R 2 
    
MW 3 LogD(7.4) 2 
    
vsurf_CW8 2 
      
PEOE_VSA_NEG 2 
      
Polarizability 2 
      
 
 
 
 
3.3 Applicability Domain and Activity Cliffs 
 
Applying the STD method as per Sushko et al.
[25]
, it is 
possible to observe an overall declining trend of accuracy vs 
STD across the majority of the single-label models (Figure 
5). Exceptions to this trend will be further explored. 
There are two main important aspects to consider for the  
quality of an AD profile, similarity of overall profiles/trends  
for the subsets of data and a decreasing accuracy as the 
chemical space moves away from the model’s core. 
Exploring Figure 5 points to only two cases where the 
requirements above have not been met; these are MDR1- 
BR and MRP2-BR in the IV set. This is not seen for the 
corresponding CC model MRP2-CC (note that MDR1 single- 
label model is same in both BR and CC models). There is 
also a mild case of disparity between IV and TE for BCRP1 
(although only at the first iteration of STD increments). While 
this disparity happens for BR, in the CC model all trends 
start  in  a  higher  point  and  tend  to  decrease  with  STD 
(although this is not done in a perfectly smooth way, as expected 
from any kind of AD analysis). 
Interestingly, even though MRP2 models show the exact 
same performance statistics at the single-label level (Table 
2), there is a marked difference between the applicability 
domain profiles of its BR and CC single-label models 
developed using a 10-fold bagging ensemble, depicted in 
Figure 5. 
Lastly, it should be noted that, for some labels, the 
increase in accuracy is not significant for smaller STD 
values. This is due to the quality of the trained model that 
may not allow a high level of precision (agreement between 
the ensemble models). Still, even if there is a small gain in 
accuracy at a given threshold, this still entails a decreased 
risk of producing a wrong prediction, and thus the respective 
AD profile is useful in guiding the prediction acceptance. 
Even  though  this  analysis  gives  insight  to  a  model’s 
overall  performance  across  the  data,  it  is  convenient  to 
10 
IV set 
MDR1 (BR/CC) 9 (50%) 18 
BCRP1 
&CC) 
(BR 4 (40%) 10 
further pinpoint activity cliff regions. Table 6 shows that a 
considerable portion of activity cliffs coincides with 
mispredictions. These can be areas of higher complexity in 
terms of the structure-property relationship that require more 
compounds and/or better use of molecular descriptors that 
would capture that subtle chemical variation.
[32] 
These can
mispredicted 
also   result  from   unreliable   experimental  data   (i.e.,  if  a 
substrate is incorrectly presented to the learning algorithm 
as a non-substrate, even if it is correctly predicted as 
substrate it will be perceived as a misprediction).
[33]
Recall that three single-label models in the multi-label 
classifier chain could use previous labels as descriptors 
(considering that MDR1, as the first label of the chain, 
cannot use previous label descriptors). The fact that in two 
out of those three models a considerable portion of the 
activity cliffs was associated with mispredictions shows the 
correlation between both. It should be pointed out that in 
both BCRP1 models (produced by the BR and CC methods) 
there were two compounds that were mispredicted in the 
former model while being correctly predicted in the latter. 
Table 6. Comparison between Activity cliffs (ACs) and 
mispredictions within them – values in brackets are the 
percentage of activity cliff compounds that are mispredicted 
by the models. 
Transporter Number of ACs Number of ACs 
MRP1 (BR & CC) 2 (100%) 2 
MRP2 (BR & CC) 0 2 
As an example, Figure 6 depicts the distribution of 
mispredictions (FN and FP) for the BCRP1 BR model 
overlaid with the substrates and  non-substrates. It  can 
be seen that activity cliffs are mainly located in areas of 
sparse data especially at the extremities of the plot. 
Mispredictions were further analyzed for their 
distribution along the TE set chemical span of each of 
the molecular descriptors used in the various decision 
trees (all distribution graphs are shown in Supporting 
Information SI 5). For all models in BR and CC, 
mispredictions overlap with correct predictions in the TE 
set. Furthermore, it is common to find both mispredicted 
compounds close to the center-values, and correctly 
predicted compounds near data limits (and even outside 
the  training range). 
BR 
MDR1 BCRP1 MRP1 MRP2 
TE set 
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Figure 5. Applicability domain evaluated with respect to the IV and TE sets. Recall that accuracy has been defined as the %  correct 
predictions out  of  the  total amount of  predictions that  fall  within any  given threshold (set  in  the  axis  labeled   “STD”). 
 
  
 
The IV and TE were also analyzed for  their 
distribution with respect to the TR chemical span. This 
revealed no apparent trend in terms of misprediction 
concentration in chemical space, with the mispredicted 
compounds often showing scattering centered at the 
median of each descriptor. As a matter of fact, 
mispredicted cases seem to follow the distribution of the 
training set, being more  densely located  near  the 
median and scattering away from it in a somewhat parallel 
manner. Additionally, both in MDR1 and BCRP1 datasets, 
despite some compounds being clear outliers with respect 
to certain individual descriptors, as seen in Supporting 
Information SI 4, falling  outside  the  maximum range of 
the training set ([0;1], standardized data) they were 
successfully predicted by  their  respective models. 
However, these observations were exceptions  and,  
overall,  the  IV  sets  were  found within 
 
the maximum range of each descriptor  in  the  training set. 
Apart from the applicability domain and activity cliff 
analysis, it is useful to analyze the range of chemical 
diversity covered by the models built, in order to support 
the validity of their future predictions. We achieved this   
by overlaying our datasets with the DrugBank dataset 
using a t-SNE multidimentional scalling projection of the 
Euclidean distances (Figure 7). Considering that 
DrugBank holds the full span of chemical variety in real- 
world drug space, this analysis provides a gauge of the 
diversity of our data. Despite the scarcity  of  data  in  
some transporter datasets they were all evenly spread 
across the chemical space of the entire DrugBank 
dataset (more than 6000 instances).  This  means  that 
the models incorporate a wide chemical variety in the 
training, which  strengthens their  potential usefulness as   
a predictive tool. 
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Figure 6. Mispredictions and activity cliffs of the BCRP1-BR model; Training data were projected into a 2D map using t-SNE, and the location 
reflects the Euclidean distance between ECFP4 fingerprints. The Tc coefficient was not used as a visualization measure as it produces plots 
with very distant points. However, using the Euclidean distance conserves visually the  relative neighborhood of  each point. Activity Cliffs are 
marked with a cross; FP: yellow; FN: red; training substrates: black; training non-substrates: white. 
 
 
 
 
 
Figure 7. Chemical space coverage of MDR1/P-gp (A), BCRP1 (B), MRP2 (C) and MRP1 (D) with respect to the DrugBank complete dataset. 
The ABC datasets are represented in red in their respective scatterplots, and DrugBank data is  depicted in  white. The  plots result from  a  t-
SNE multidimentional scalling projection of  the Euclidean distance calculated from  ECFP4 fingerprints. 
C D 
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4 Discussion 
 
4.1 Multi-label QSAR models 
 
In this work we sought out to build multi-label models using a 
decision tree learner to predict compounds binding to several 
ABC transporters as substrates. The main advantage of using 
decision trees to build a predictive model is that their visual 
and transparent nature allows interpretation of the effects of 
the features on the predicted labels. Furthermore, decision 
trees can cope with different scales in the descriptors and they 
can   also   handle   both   continuous   and   categorical   data 
efficiently and robustly.[34] In order to test whether there is a 
correlation between the binding profiles of different ABCs, two 
types of multi-label models (BR and CC) differing only in the 
ability to address overlap between labels were implemented in 
the modeling of ABC substrate recognition. Despite the 
substrate  overlap  between  various  members  of  the  ABC 
transporters 
38, 39
, BR and CC yielded very similar predictive 
performance statistics. On the other hand, it is apparent that 
the predicted MDR1 class is favored over molecular 
descriptors in the BCRP1 model, and the predicted  MRP2 
class is preferred in the MRP1 model, as evidenced by the 
preferential selection of these features as one of the top five 
model features (compare BR and CC features in Table 4 and 
Table 5). There are several possible explanations for the lack 
of a significant improvement of CC comparatively to BR (Table 
3). The first explanation may be that labels have close to no 
interaction, which means that the classifier chain has nothing 
to capitalize from. However, Table 1 shows that all pairs of 
labels, except one, have a significant correlation, so the issue 
with regard to this hypothesis may be the relatively low label 
density (the compound vs label matrix is only 23% populated 
in the training set), which reveals scarcity of multi-label cases 
(i.e., compounds with measured binding in several transporter 
systems). The second explanation may be due to the fact that 
the BR model depends on the individual quality of each single-
label model; while the quality of the CC model depends also 
on the quality of the prediction of the previous labels in the 
chain. In fact, in a CC model every flaw in any given label 
(transporter) will be carried on to the following labels in the 
chain, as opposed to BR, in which the shortcomings of  a 
model have no effect on the remaining labels. 
Even though the final overall statistics show no marked 
improvement from accounting for label interaction,  focusing 
only on this can give an overly simplistic view. When results 
are analyzed as a whole, there are several evidences of the 
value of using label interaction in the modelling of the ABC 
QSAR. In two of the three single-label models, built by the CC 
method, where previous labels were available, previous label 
information was spontaneously selected by the tree building 
algorithm. Furthermore, this singular change in the entire 
modelling process coincided with more parsimonious models, 
which showed more balanced SEN to SPE ratio. This is a very 
valuable improvement given that this modelling task would 
naturally tend towards higher SEN, brought on by an 
imbalance  in  the  data  (high  ratio  of  substrates  to  non- 
substrates). Data imbalance is known to have yielded poor 
models in the past
[33, 35]
, and being able to mitigate this issue 
without using any type of aiding technique (i.e., over-/under- 
sampling or misclassification cost) is notable. Lastly, the 
presence  of  previous  labels  allowed  establishing  a  more 
 
reliable AD of the model. This is observed with MRP2 models, 
where even though both MRP2-CC and MRP2-BR yielded 
equal predictive performance, MRP2-CC allows a better 
definition of its applicability as both external datasets show the 
same trend of accuracy vs STD (Figure 5). As the AD method 
is insensitive to bias and relies solely on precision, low STD 
scores may happen due to a systematic misprediction in all 
models in the ensemble rather than a reliable (correct) 
prediction. This systematic misprediction in low STD area was 
the case in MRP2-BR. On the other hand, the presence of two 
extra features in MRP2-CC (the two previous labels in the 
chain), which were picked for 3 of the 10 bagged models, 
helped overcome the systematic bias in modelling MRP2 data. 
Therefore, MRP2-CC allows establishing a threshold of 
prediction reliability that imitates the reliability trend in external 
data. As a result, these observations consist of a proof of 
concept of the value of using CC for the purpose of modelling 
ABC substrate data. 
Activity cliff analysis was used in this study to identify areas of 
high complexity in the structure-activity data. There was a high 
incidence of mispredictions in the activity cliff areas. 
An analysis of outliers showed a lack of correlation between 
location in descriptor span and misprediction. This is an 
indication that the misprediction rate appears to have no 
connection with the descriptor span coverage by the model. 
The performance of our models has to be evaluated in light 
of the high level of noise in any kind of large transporter 
dataset. Several factors are known to contribute to the 
considerable inter-laboratory and even inter-experimental 
variability in permeability/efflux assays. Some frequently 
reported examples are sensitivity to varied culture protocols 
and conditions, genetic change of MDR1 (and other 
transporters) leading to variable pump functionality, and 
variable  expression  levels  of  various  ABC  transporters and 
even  different additional transporters  (i.e. Solute Carriers).[
36-
 
37]   
There   are   also   parallel   metabolizing   enzymes   and 
alternative active transport systems. The variability is 
therefore a significant factor within a single dataset built from 
different sources using different cell models.
[38] 
As a result, the 
BR and CC models should be evaluated in light of realistic 
maximum obtainable performance. In an ideal scenario a 
perfect model would correctly classify 100% of unambiguous 
cases (correctly belonging to their assigned classes), and 
would correctly classify 50% of ambiguous cases (given that 
probabilistically only 50% are actually correctly classified to 
begin with). Applying this reasoning to our dataset translates 
into a maximum accuracy of 98% since our dataset has 61 
ambiguous responses (i.e. reported as substrate and non- 
substrate from different sources) across 1493 compounds, 
hence 2% will theoretically be mispredicted. However this is a 
conservative estimate, due to the inter-laboratory variations 
affecting the accuracy of a given label in the literature, where 
the majority of compounds in the dataset have only one 
experimental measurement. It must be noted that in the 
construction  of  Metrabase,  the  allocation  of  substrate  and 
non-substrate labels was carried based solely on the 
recommendation of the original literature reference.
[12] 
However different literature sources have differing criteria and 
threshold values (in addition to varying experimental 
techniques) for classifying a compound as substrate.
[39] 
A 
threshold  of  2  for  the  efflux  ratio  is  normally  used  by 
researchers, while the borderline interval is [1.8-2.5].
[39] 
In fact 
a maximum accuracy of 86% has been reported for MDR1 
efflux assays.
[39] 
In an overall appreciation of the feasibility of 
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using the models presented here, as a substitute of the gold 
standard cell assays, these models are able to produce valid 
predictions in 70% of the cases while the Borst cell assay 
(n=91, see Broccatelli et al.
[39]
) produced usable prediction in 
76%  of  the  cases  considering  that  contradictory  replicates 
(n=16) and borderline values (n=6) cannot be used  to 
trustfully classify a given compound. 
In this study, even for models that were trained on datasets 
with balanced classes, the specificity is always considerably 
lower than the sensitivity, which means that the models are 
generally more capable of identifying substrates than non- 
substrates. However, this is not unprecedented as several 
other  works  on  MDR1  substrate  prediction  listed  in  the 
literature
[39]  
have  reported  the  same  issue.  Comparing  the 
results of two previous works where efflux ratios of 2
[39] 
vs 
2.5
[40] 
have been used as threshold values, models with 
higher threshold values generally lead to lower specificity as 
expected. It can be hypothesized that the main underlying 
cause for a tendency for poor SPE is the fact that some 
substrates also have high passive permeability. This leads to 
cases of substrates that cannot be identified by permeability 
measurement methods (false non-substrates), which will 
translate into spurious data in the non-substrate class.
[39]
 
To contextualize the potential utility of the CC model 
proposed here, as of 2012, Tsaioun and Kates
[41] 
reported a 
15% increase in phase 2 failures, 50%  of which are due to 
lack of efficacy. However, many of these failures are CNS- 
targeted clinical trials where lack of efficacy is caused by an 
underlying failure to permeate the blood brain barrier  (BBB). It 
is safe to say that, considering the polyspecificity of MDR1 in 
addition to the presence of a large variety of other ABC 
exporters on the BBB, a large portion of this attrition rate could 
probably be associated to some extent with the efflux of the 
drugs in question. In fact, in retrospect it is possible to identify 
cases where, if our models had been used, it would have   
been possible to avoid very expensive clinical trials through 
the prediction of the substrate ability of different ABC 
substrates. Two examples from our test set are sunitinib and 
dasatinib, both predicted as MDR1 and BCRP1 substrates 
based on our CC and BR models. Sunitinib failed a phase II 
clinical trial (NCT00923117) for the treatment of glioblastoma 
due to lack of efficacy. The probable cause for such  late 
failure  was  that  this  drug  has  poor  ability  to  permeate the 
BBB, which is most likely due to MDR1 and BCRP1 efflux.
[42]
 
In retrospect, if the models herein developed had been 
applied to sunitinib, it would be possible to avoid a failed 
clinical trial since both BR and CC were able to predict this 
compound as a substrate of both transporters. Even if the trial 
was carried out, the use of a predictive model like ours would 
at the least maximize the chances of success with the 
concomitant administration of an inhibitor. A similar scenario 
was  observed  for dasatinib, which  showed  no effectivity  in a 
clinical study with 14 patients.
[43]
 
 
4.2 Molecular descriptors in the single-label elements of 
the models 
 
In this investigation we used five pre-processing wrapper 
methods to find the best set of molecular descriptors that can 
produce the most accurate J48 models for the prediction of 
each of the four labels (transporters’ substrates/non- 
substrates). Among the five feature selection methods, J48- 
GA features yielded the best results for the majority of single- 
label models. The purpose of using a wrapper rather than a 
filter method is to select a feature set that ideally best copes 
with the classification algorithm’s biases. However, given the 
complex  nature  of  these  transporters  it  is  expected  that 
different  feature-selection  methods  are  best  suited  for  the 
predictions of different labels, and indeed this has been 
observed in our results. 
Common features between transporters could be an indication 
of the degree of shared substrates. MDR1 and MRP1 both 
share the same best feature selection method (J48-GA) and 
there is some degree of feature overlap (around 5 features) 
between them. MDR1 shows the strongest correlation with 
MRP1 (Chi-squared test, p < 0.001, Table 1), and in fact there 
is a considerable amount of common substrates and non- 
substrates between them (n=34 and n=12, respectively out of 
61 common compounds). The overlap of substrates between 
various      ABC       transporters      is      a      well-established 
phenomenon.
[44]   
For   instance,   it   was   reported   that drug 
resistance to daunorubicin derives from a synergy between 
MRP1 and MDR1 activities.
[45]
 
The nature of the molecular descriptors incorporated into 
the single label J48 models can be interpreted in order to 
identify the molecular characteristics leading to a compound 
being recognized by a transporter as its substrate (See the 
Supporting Information Table SI 3). 
 
5 Conclusions 
 
In conclusion, this work reports two multi-label models for 
the prediction of various ABC transporter substrates and non- 
substrates, namely BCRP1, MDR1/P-gp, MRP1 and MRP2. 
The multi-label classifier chain method, which accounts  for 
label (transporter) interaction, was compared with the binary 
relevance method, which does not consider interaction. Both 
models showed good predictive power, as expressed by F1 
values (weighted average of precision and recall) and a 
balanced accuracy of approximately 70%. Even though the   
CC model showed no marked improvement in terms of the 
general performance measures, a closer analysis revealed 
several evidences of the benefit of taking into account label 
interaction. Firstly, despite the natural tendency for a relatively 
poorer ability to classify non-substrates (as they are the 
minority class, and are also more prone to containing noisy 
data), the CC model showed more balanced single-label 
models that compromised slightly on SEN (sensitivity) to gain 
some SPE (specificity). This translates into a lower ΔPR 
measure (average deviation in precision and recall) for the CC 
model, indicative of less discrepancy between the ability to 
predict substrates and non-substrates. Secondly, two of the 
single-label models used other predicted labels in preference 
to the molecular descriptors during the CC training, leading to 
improved SEN to SPE balance. Thirdly, the two MRP2 single- 
label models within CC and BR, despite showing the same 
predictive accuracy performance, resulted in two very different 
applicability domain profiles. While MRP2-CC allowed 
establishing a more reliable accuracy vs STD profile, which 
emulates more closely the reliability profile in external data, 
MRP2-BR was not able to achieve this. We hypothesize the 
presence of previous label predictions allowed overcoming a 
systematic bias in the ensemble predictions, as this is the only 
aspect that changed between BR and CC. These 
observations consist of a proof of concept of the utility of 
addressing transporter overlap when modelling a QSAR, and 
possibly more marked effects could be obtained with a more 
populated matrix of instances vs transporters. 
An analysis of the molecular features showed that there is 
some degree of overlap between transporters in terms of the 
molecular features responsible for substrate recognition, which 
supports the multi-label approach from a mechanistic 
standpoint. In particular, features of MDR1 and BCRP1 
substrates have some similarity as both transporter’s 
substrates  are  bulky  and  flexible,  and  contain  hydrophobic 
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moieties. MDR1 substrates are highly branched, good 
electron acceptors (such as in hydrogen bonds) and contain 
quaternary ammoniums, while BCRP1 substrates contain 
large positively charged surface, have aromatic rings and may 
be a non-drug-like molecule. The correlation of these two 
transporters is evidenced by the fact that the predicted MDR1 
label is a very useful feature for the classification of BCRP1 
transport. On the other hand, molecular features of MRP2 and 
MRP1 substrates are also similar in terms of polarity and 
hydrophilicity of the molecular surface. MRP2 substrates may 
contain reactive groups defined as nitrogen, oxygen and sulfur 
atoms with polar negative surface area, while MRP2 
substrates are flexible in addition to large polar and 
hydrophilic surface area. Furthermore, the predicted MRP2 
binding class can be used as a significant feature for the 
prediction of MRP1 transport. MDR1 and BCRP1 were more 
associated with explicit aromaticity-related features, whereas 
MRP1 and MRP2 where predominately more associated with 
hydrophilicity-related properties, which could be tied with the 
fact that MDR1 and MRP2 were used as predictors in both 
BCRP1 and MRP1 models respectively. 
Overall, the models revealed to be robust and of acceptable 
predictive performance, especially considering the complexity 
of trying to uncover unspecific mechanisms of substrates 
recognition by the ABC family members. 
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